Press Release
ionscope raises funds
Imperial Innovations Group plcPosted on:07 Aug 07Imperial Innovations Group plc
(“Imperial Innovations”)
ionscope raises funds
Imperial Innovations Group plc (AIM: IVO) today announces that ionscope Ltd (“ionscope”), a microscope technology company formed by Imperial Innovations, has successfully raised £680,000 from individual investors belonging to the Cambridge Angels Group.
ionscope’s products are based on a technique called Scanning Ion Conductance Microscopy (SICM) and are able to produce images of living cell membranes at resolutions fifty times greater than achievable using a conventional optical microscope. Other high magnification techniques interfere with or kill living cells, whereas SICM is benign, allowing living cells to be studied over long periods. The technique has application in the study of living processes at nano-scale, which to date has included neurons, heart muscle, kidney, sperm and stem cells.
The company started shipping product to customers around the world earlier this year. The investment proceeds will be used to extend its marketing reach, build delivery capacity, speed product development and grow its intellectual property portfolio.
Dr Max Wilson (Chairman of ionscope) commented “This investment will enable ionscope to realise the huge potential of ScanIC microscopy in the research market. We are excited by the opportunity to put this important new technique into the hands of researchers more quickly.
-Ends-
For more information contact:
Imperial Innovations
Susan Searle, Chief Executive Officer +44 (0)20 7594 6591
Lucy Ahfong, Marketing Communications Executive +44 (0)20 7594 6644
M:Communications
Patrick d’Ancona / Eleanor Williamson +44 (0)20 7153 1539
JPMorgan Cazenove (NOMAD to Imperial Innovations)
Steve Baldwin
+44(0)20 7588 2828
Notes to Editors
About Imperial Innovations
Imperial Innovations is one of the UK's leading technology transfer and commercialisation companies. The company was founded in 1986 and its ordinary shares admitted to trading on the AIM Market of London Stock Exchange plc in July 2006, raising £25 million at an offer price of 365p and £1 million by means of a public offer.
The company’s integrated approach encompasses the identification of ideas, protection of intellectual property, development and licensing of technology and formation, incubation and investment in technology businesses. A wide range of technologies are commercialised within the areas of healthcare, energy, environment and emerging technology trends.
Based at Imperial College London, the company has established equity holdings in 70 technology businesses and has completed 116 commercial agreements. Imperial Innovations also commercialises technologies originating from outside Imperial College through incubation contracts with the Carbon Trust and WRAP and has commercialisation contracts with a number of multinational corporations including BAE Systems.
www.imperialinnovations.co.uk
About ionscope Limited
ionscope was established in 2002 to commercially exploit scanning ion conductance microscopy (SICM) which has been developed by a joint team of scientists from Imperial College, London and the University of Cambridge. Publication of research using this technique has stimulated significant interest from groups around the world working in biology, biochemistry, medicine and drug discovery. SICM is also capable of nano-scale printing and fabrication with biological molecules.
ionscope works closely with a biophysics group in the Division of Medicine at the Hammersmith Campus of Imperial College. Recently ionscope established a facility to demonstrate SICM in the BioNanotechnology Centre.Editor's Details
Patrick d'Ancona
dAncona@MComGroup.com
(“Imperial Innovations”)
ionscope raises funds
Imperial Innovations Group plc (AIM: IVO) today announces that ionscope Ltd (“ionscope”), a microscope technology company formed by Imperial Innovations, has successfully raised £680,000 from individual investors belonging to the Cambridge Angels Group.
ionscope’s products are based on a technique called Scanning Ion Conductance Microscopy (SICM) and are able to produce images of living cell membranes at resolutions fifty times greater than achievable using a conventional optical microscope. Other high magnification techniques interfere with or kill living cells, whereas SICM is benign, allowing living cells to be studied over long periods. The technique has application in the study of living processes at nano-scale, which to date has included neurons, heart muscle, kidney, sperm and stem cells.
The company started shipping product to customers around the world earlier this year. The investment proceeds will be used to extend its marketing reach, build delivery capacity, speed product development and grow its intellectual property portfolio.
Dr Max Wilson (Chairman of ionscope) commented “This investment will enable ionscope to realise the huge potential of ScanIC microscopy in the research market. We are excited by the opportunity to put this important new technique into the hands of researchers more quickly.
-Ends-
For more information contact:
Imperial Innovations
Susan Searle, Chief Executive Officer +44 (0)20 7594 6591
Lucy Ahfong, Marketing Communications Executive +44 (0)20 7594 6644
M:Communications
Patrick d’Ancona / Eleanor Williamson +44 (0)20 7153 1539
JPMorgan Cazenove (NOMAD to Imperial Innovations)
Steve Baldwin
+44(0)20 7588 2828
Notes to Editors
About Imperial Innovations
Imperial Innovations is one of the UK's leading technology transfer and commercialisation companies. The company was founded in 1986 and its ordinary shares admitted to trading on the AIM Market of London Stock Exchange plc in July 2006, raising £25 million at an offer price of 365p and £1 million by means of a public offer.
The company’s integrated approach encompasses the identification of ideas, protection of intellectual property, development and licensing of technology and formation, incubation and investment in technology businesses. A wide range of technologies are commercialised within the areas of healthcare, energy, environment and emerging technology trends.
Based at Imperial College London, the company has established equity holdings in 70 technology businesses and has completed 116 commercial agreements. Imperial Innovations also commercialises technologies originating from outside Imperial College through incubation contracts with the Carbon Trust and WRAP and has commercialisation contracts with a number of multinational corporations including BAE Systems.
www.imperialinnovations.co.uk
About ionscope Limited
ionscope was established in 2002 to commercially exploit scanning ion conductance microscopy (SICM) which has been developed by a joint team of scientists from Imperial College, London and the University of Cambridge. Publication of research using this technique has stimulated significant interest from groups around the world working in biology, biochemistry, medicine and drug discovery. SICM is also capable of nano-scale printing and fabrication with biological molecules.
ionscope works closely with a biophysics group in the Division of Medicine at the Hammersmith Campus of Imperial College. Recently ionscope established a facility to demonstrate SICM in the BioNanotechnology Centre.Editor's Details
Patrick d'Ancona
dAncona@MComGroup.com
Advertising
Comments